Israeli Legislation.com

Regulation of Research into Biological Disease Agents Law, 5769-2008

חוק הסדרת מחקרים במחוללי מחלות ביולוגיים, תשס"ט-2008

Published: 2008-11-12Consolidated Hebrew text as of 2020-12-22 · Last amended 2016-06-23✓ Amendment status checked against the Knesset legislation record on 2026-11-10
Premium
Unofficial English translation — for reference only. It may contain errors or omissions and cannot be relied on as a legal text. Only the Hebrew text published in Reshumot is legally binding.More

This English text was translated from the official Hebrew using a range of translation tools, and it undergoes ongoing checks and updates. It is not a certified translation.

Despite these checks, it may contain errors, omissions, or imprecise renderings of legal terminology and cross-references, and it may not yet reflect the latest amendments. It cannot be relied upon as a legal text.

The Hebrew text as published in Reshumot (ספר החוקים) and on the Knesset website is the sole authoritative and legally binding version. In any discrepancy, the Hebrew text prevails.

This translation is provided for informational purposes only and does not constitute legal advice. For use in legal proceedings, request a certified Expert Legal Opinion.

Chapter I: General

Definitions§

1.

In this Law –

"institutional committee" – an external institutional committee established pursuant to the provisions of section 12 or an internal institutional committee established pursuant to the provisions of section 13;

"host range" – the variety of living organisms that a microbiological agent is capable of infecting and reproducing within;

"institution" – a corporation or body of persons conducting research-scientific, medical, industrial-commercial or educational activity, including a hospital and a governmental institution;

"the Council" – the Council for Research into Biological Disease Agents appointed pursuant to the provisions of Chapter III of this Law;

"disease agents" – bacteria, viruses, fungi, prions and toxins or components thereof, capable of causing diseases in humans and listed in the Schedule;

"the Director" – the Director General of the Ministry of Health or an employee of the Ministry of Health whom he has authorised for this purpose;

"the security establishment" – the Ministry of Defence and its subsidiary units, the subsidiary units of the Prime Minister's Office whose principal activity is in the field of state security and its foreign relations, the Israel Defence Forces, or any other body whose activity the Prime Minister or the Minister of Defence has approved as being in the field of state security for the purposes of this Law;

"security offence" – an offence under any of the following:

(1)Section B or Section D of Chapter VII of the Penal Law, 5737-1977 (in this Law – the Penal Law), and also sections 143, 144, 146 and 147 of that Law;
(2)regulations 58, 59, 62, 64, 66, 67, 84 and 85 of the Defence (Emergency) Regulations, 1945;
(3)sections 2 or 3 of the Prevention of Terrorism Ordinance, 5708-1948;
(4)the Infiltration Prevention (Offences and Jurisdiction) Law, 5714-1954;
(5)section 8 of the Prohibition of Terrorist Financing Law, 5765-2005;
(6)a terrorism offence as defined in the Counter-Terrorism Law, 5776-2016, except for an offence under sections 26, 32 and 36 of that Law;

"the Minister" – the Minister of Health.

Chapter II: Conducting Research into Disease Agents and Other Research

Possession of Disease Agents and Conducting Research therein§

2.
(a)No person or institution shall possess disease agents or conduct research therein, including applied or diagnostic research (in this Law – research), except at an institution that the Director has recognised for this purpose pursuant to the provisions of section 5 (in this Law – a recognised institution).
(b)A recognised institution shall not possess disease agents or conduct research therein except after having received approval from an institutional committee for the possession of the disease agents or for the conduct of the research, as the case may be, pursuant to the provisions of section 12(b) or 13(c) and in accordance with the conditions of the approval.
(c)
(1)No person or institution shall possess disease agents or conduct research therein except in a manner that will not endanger state security or public safety, health or welfare;
(2)The Minister, after consulting with the Minister of Defence and with the approval of the Science and Technology Committee of the Knesset, shall prescribe provisions regarding the possession of disease agents and the conduct of research therein, including regarding the transport, storage and management of inventory, in a manner that will not endanger state security or public safety, health or welfare.

Other Research§

3.
(a)No person shall conduct research whose sole purpose is to cause a disease or aggravate it, or to harm the ability to prevent a disease or to treat it.
(b)
(1)A person or institution that has conducted research for which there is no obligation to obtain approval for its conduct under this Law, and in the course of the research discovered findings capable of increasing the virulence of disease agents not included in the Schedule or of increasing their transmissibility, or capable of altering the host range of such disease agents so that the disease may be transmitted to humans, shall cease the research and act in accordance with the following provisions:
(a)where the research was conducted at a recognised institution – the researcher shall submit an application pursuant to section 5 to the internal institutional committee, or, in its absence, to the external institutional committee, for approval to continue the research;
(b)where the research was conducted otherwise than at a recognised institution – the researcher shall submit an application pursuant to section 5 to the external institutional committee for approval to continue the research.
(2)In special cases, where an institutional committee finds that the anticipated harm to the research outweighs the concern of harm to state security or to public order, health or security, it may direct the researcher as to the continuation of its conduct pending its determination of the application as aforesaid.
(3)The provisions of Chapter IV shall apply to research as referred to in this subsection, with the necessary modifications.

Recognition of an Institution§

4.
(a)The Director may recognise an institution as an institution entitled to possess disease agents or to conduct research, if he has found, after consulting with the Council, that the possession of disease agents or the conduct of research as aforesaid at the institution is not liable to endanger state security or public safety, health or welfare, and after he has satisfied himself that the institution is capable of meeting the requirements under this Law.
(b)Within the framework of the recognition of an institution pursuant to the provisions of subsection (a), the Director shall determine whether the institution is entitled to establish an internal institutional committee pursuant to the provisions of section 13.
(c)The Director may, after consulting with the Council, revoke a recognition granted pursuant to subsection (a), or an approval to establish an internal institutional committee granted pursuant to subsection (b), if he has found that the possession of disease agents or the conduct of research at the institution is liable to endanger state security or public safety, health or welfare, or if he has found that the institution is not complying with the provisions prescribed under this Law or given to it by the Director or the institutional committee.
(d)Before the Director decides not to recognise an institution or to revoke a recognition or an approval to establish an internal institutional committee that has been granted, the institution shall be given an opportunity to present its arguments in the matter.

Application to Possess Disease Agents or to Conduct Research therein§

5.

A person seeking to possess disease agents or to conduct research therein shall submit an application to the internal institutional committee at a recognised institution, or in its absence, to the external institutional committee.

Chapter III: The Council for Research into Disease Agents

The Council for Research into Disease Agents§

6.
(a)The Minister, after consulting with the President of the Israel National Academy of Sciences and with the Head of the National Security Staff, shall appoint a Council for Research into Disease Agents, which shall comprise 15 members.
(b)The following are the members of the Council:
(1)six experts in the fields of microbiology, infectious diseases or biotechnology, to be selected by the Minister from lists submitted by academic research institutions, including hospitals; the Minister shall appoint, as provided in subsection (a), one of them to be the chairperson;
(2)a representative of the Ministry of Health;
(3)a representative of the Ministry of Science, Culture and Sport, upon the recommendation of the Minister of Science, Culture and Sport;
(4)a representative of the Ministry of Environmental Protection, upon the recommendation of the Minister of Environmental Protection;
(5)a representative of the Ministry of Agriculture and Rural Development, upon the recommendation of the Minister of Agriculture and Rural Development;
(6)a representative of the Minister of Industry, Trade and Employment, upon the recommendation of the Minister of Industry, Trade and Employment;
(7)a representative of the Israel Police, upon the recommendation of the Minister of Internal Security;
(8)a representative of the Ministry of Defence, upon the recommendation of the Minister of Defence;
(9)a representative of the National Security Staff;
(10)a representative of the Manufacturers Association.
(c)The area of expertise of the representatives listed in paragraphs (2) to (5) of subsection (b) shall be in one of the fields listed in subsection (b)(1).
(d)A person who has been convicted of security offences or of an offence which, by reason of its nature, gravity or circumstances, renders him unfit to serve as a member of the Council, shall not be appointed as a member of the Council.
(e)The term of office of a member of the Council is four years and he may be reappointed for one additional term of office.

Vacation of Office§

7.
(a)A member of the Council shall cease to serve before the expiry of his term of office in any of the following circumstances:
(1)he resigned by delivering a letter of resignation to the Minister;
(2)he has been permanently prevented from fulfilling his duties, or the continuation of his membership of the Council entails a substantial impairment of the Council's functioning, and the Minister, after consulting with the chairperson of the Council, has removed him from office by written notice;
(3)he was absent from three consecutive meetings, except for an absence due to illness, due to service in the Israel Defence Forces, or with the prior written approval of the chairperson of the Council;
(4)he has ceased to satisfy one of the conditions for his appointment.
(b)Where an indictment has been filed against a member of the Council for a security offence or for an offence which, by reason of its nature, gravity or circumstances, renders him unfit to serve as a member of the Council, the Minister may suspend him from office until a final judgment is given in his matter.
(c)Where the term of office of a member of the Council has ended, or a member of the Council has been suspended from office, the Minister shall appoint another in his place, on behalf of the same body that the member whose term of office ended or who was suspended represented pursuant to the provisions of this section; the appointment of a substitute for a member of the Council who has been suspended from office shall be for the duration of the suspension.

Functions of the Council§

8.

The functions of the Council are:

(1)to advise the Minister in formulating provisions regarding the possession of disease agents and research therein, regarding research under section 3(b), and regarding amendment of the Schedule;
(2)to advise the Director regarding the recognition of institutions;
(3)to advise the Director in examining an objection submitted pursuant to the provisions of section 17;
(4)to initiate information programmes on matters within its sphere of activity and training and instruction programmes for researchers on matters related to the conduct of research into disease agents and research under section 3(b);
(5)to approve the rules for the operation of the institutional committees pursuant to the provisions of sections 12 and 13;
(6)to supervise the implementation of the provisions of this Law and compliance with the rules for the operation of the institutional committees.

Convening and Working Procedures§

9.
(a)The Council shall convene from time to time, and at least three times a year, and the Minister or the Director may convene it as they see fit.
(b)A majority of the members of the Council shall constitute a quorum for the approval of rules and the adoption of decisions.
(c)The Council shall determine its working procedures to the extent that they have not been prescribed in or under this Law, and may determine, inter alia, that its deliberations shall be conducted in camera.
(d)The Council shall submit to the Minister and to the Science and Technology Committee of the Knesset a report of all its activities, once a year.
(e)The Council shall maintain working relations, cooperation and exchanges of knowledge with similar bodies worldwide.

Visits by a Member of the Council§

10.

A member of the Council may, with the approval of the chairperson of the Council or pursuant to rules to be determined by him, and after giving advance notice, visit any place where research is being carried out, provided that he takes the customary measures necessary to prevent harm to the research.

Appointment of Office Holders§

11.

The Minister shall appoint a professional coordinator and an assistant to the professional coordinator from among the employees of the Ministry of Health who are subordinate to the Chief Scientist of the Ministry, and they shall be responsible for the ongoing work of the Council.

Chapter IV: Institutional Committees

External Institutional Committee§

12.
(a)The Director shall appoint from among the members of the Council the external institutional committee, whose members shall be three of the members listed in section 6(b)(1) and the members listed in section 6(b)(2), (6) and (7), one of whom shall be the chairperson, as the Director shall direct.
(b)The external institutional committee shall grant approvals for the possession of disease agents and the conduct of research therein, and shall supervise research for which approval has been granted to conduct and the implementation of the provisions under this Law at institutions that do not have an internal institutional committee.
(c)The external institutional committee shall determine, with the approval of the Council, its working procedures.

Internal Institutional Committee§

13.
(a)An internal institutional committee shall comprise three members who are senior researchers at the institution and whose area of expertise is microbiology, infectious diseases or biotechnology, one of whom shall be the chairperson.
(b)In making its decisions, an internal institutional committee shall consult with the security officer and with the safety officer of the institution, and these persons may serve as observers at its deliberations.
(c)An internal institutional committee shall grant approvals for the possession of disease agents and the conduct of research therein pursuant to the provisions of this Law, and shall supervise research for which approval has been granted to conduct and the implementation of the provisions under this Law at the institution in which it operates.
(d)An internal institutional committee shall determine, with the approval of the Council, its working procedures.

Powers of an Institutional Committee§

14.

For the purpose of fulfilling the functions of an institutional committee under this Law, its members may:

(1)request an inspector authorised pursuant to the provisions of section 18 to exercise his powers under section 19, and also accompany an inspector upon entry to a place where research approved by the institutional committee of which they are members is being conducted, in order to examine the place and the manner in which the research is being conducted and to require him to transfer to them samples taken as referred to in section 19; samples taken pursuant to this section shall be delivered to the Director upon his demand;
(2)require any person to provide the institutional committee with information and documents relating to research that it has approved to conduct.

Approval by an Institutional Committee to Possess Disease Agents and to Conduct Research therein§

15.
(a)An institutional committee shall approve the possession of disease agents or the conduct of research therein if it is satisfied that all of the following are met:
(1)the conduct of the research is not liable to endanger state security or public safety, health or welfare; among its considerations the committee shall take into account, inter alia, the following considerations relating to the purpose of the research:
(a)increasing the harm that disease agents are liable to cause;
(b)increasing the stability of disease agents to medicinal means, disinfection means or various physical conditions;
(c)rendering the disease agents more difficult to detect or identify;
(2)the conduct of the research complies with the requirements and procedures, including the safety rules under any law, regarding the possession of disease agents or regarding the conduct of research therein, including regarding the required equipment and the research team and its training.
(b)An institutional committee shall not approve the possession of disease agents or the conduct of research therein unless:
(1)the institution at which the disease agents are to be possessed or the research is to be conducted has a written guidelines file concerning the rules for the possession of disease agents and for the conduct of research under this Law;
(2)the researcher has submitted a declaration, drawn up and signed in accordance with law and in accordance with the provisions prescribed by the Minister, attesting that he has not been convicted of a security offence.
(c)For the purpose of granting approval as referred to in this section, an institutional committee may require the applicant for approval to provide any additional data or information required by it for the purpose of examining the application.
(d)The institutional committee shall not refuse to approve an application where it is possible to approve it subject to conditions, or, in the case of an application for approval of research, to limit the research and give directions regarding the manner of its conduct.
(e)If an institutional committee finds that an approval it has granted is liable to endanger state security or public safety, health or welfare, or that it granted an approval as aforesaid in error or on the basis of incorrect data, or that the research is not being conducted in accordance with the conditions and restrictions it has prescribed, it may prescribe new conditions for the approval or limit it, and may revoke an approval it has granted.
(f)A decision of an institutional committee pursuant to subsection (e) shall be given after the researcher has been given an opportunity to present his arguments; however, an institutional committee may hear such arguments after the revocation of the approval, if it has found that delaying its revocation is liable to cause harm to state security or to public safety, health or welfare.

Reporting to the Director on the Granting of Approvals§

16.
(a)The institutional committee shall report to the Director on the granting of an approval pursuant to sections 3(b), 12(b) or 13(c) within three days of the date of granting the approval; the Director shall direct the manner of reporting pursuant to this section.
(b)If the Director considers that there is a concern that an approval granted by an institutional committee is liable to endanger state security or public safety, health or welfare, or that the conditions for approval of the application pursuant to the provisions of section 15 were not met, he may, within 14 days of the date of receipt of the report on the approval as referred to in subsection (a), give notice of the suspension of that approval and re-examine the application.
(c)Where the Director has suspended an approval pursuant to the provisions of subsection (b), he shall give his decision in the matter within 21 days of the date on which the approval was suspended.

Objection to a Decision of an Institutional Committee§

17.
(a)An institution or a researcher may submit an objection to the Director against a decision of an institutional committee under sections 3(b), 12(b) or 13(c).
(b)The Director shall give his decision on the objection within 30 days of the date of its submission.

Page 1 of 2

Read the entire law on one page — continuous text, no page breaks, plus formal citations.

LawHealth

חוק הסדרת מחקרים במחוללי מחלות ביולוגיים, תשס"ט-2008

Biological Disease Agents Law

Regulation of Research into Biological Disease Agents

Regulation of Biological Research Law

Biological Pathogens Research Law

Disease Agents Research Law

Biosafety research regulation

Biological agents research

Pathogenic research regulation

Biological containment law

Dangerous pathogens research law